Cargando…
Sustained seroprevalence of SARS-CoV-2 antibodies 1 year after infection: One of the first COVID-19 cluster cases in Bosnia and Herzegovina
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is a novel virus that has been identified as a causal agent of COVID-19, an emergent infectious disease which brought about a new pandemic in the 21(st) century. The immune responses and clinical features of individuals infected with...
Autores principales: | Šušak, Božo, Mikulić, Vinka, Lazarević, Armina, Mikulić, Ivanka, Arapović, Jurica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860308/ https://www.ncbi.nlm.nih.gov/pubmed/34392826 http://dx.doi.org/10.17305/bjbms.2021.6340 |
Ejemplares similares
-
The First Evidence of Lyme Neuroborreliosis in Southern Bosnia and Herzegovina
por: Arapovic, Jurica, et al.
Publicado: (2014) -
The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience
por: Arapović, Jurica, et al.
Publicado: (2020) -
Feasibility and sustainability of dietary surveillance, Bosnia and Herzegovina
por: Gicevic, Selma, et al.
Publicado: (2019) -
Urine neutrophil gelatinase-associated lipocalin concentration in healthy newborns during the first three postnatal days
por: Mikulić, Vinka, et al.
Publicado: (2020) -
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina—One year later
por: Prguda-Mujic, Jasminka, et al.
Publicado: (2022)